These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18473766)

  • 1. Mucosal T cell proliferation and apoptosis in inflammatory bowel disease.
    Sturm A; de Souza HS; Fiocchi C
    Curr Drug Targets; 2008 May; 9(5):381-7. PubMed ID: 18473766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Hiejima E; Kawai T; Nakase H; Tsuruyama T; Morimoto T; Yasumi T; Taga T; Kanegane H; Hori M; Ohmori K; Higuchi T; Matsuura M; Yoshino T; Ikeuchi H; Kawada K; Sakai Y; Kitazume MT; Hisamatsu T; Chiba T; Nishikomori R; Heike T
    Inflamm Bowel Dis; 2015 Jul; 21(7):1529-40. PubMed ID: 25946569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T-cell apoptosis in inflammatory bowel disease: to die or not to die, that is the mucosal question.
    Neurath MF; Finotto S; Fuss I; Boirivant M; Galle PR; Strober W
    Trends Immunol; 2001 Jan; 22(1):21-6. PubMed ID: 11286687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging immunological targets in inflammatory bowel disease.
    Monteleone G; Pallone F; MacDonald TT
    Curr Opin Pharmacol; 2011 Dec; 11(6):640-5. PubMed ID: 22000933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
    Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
    J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation.
    Musso A; Dentelli P; Carlino A; Chiusa L; Repici A; Sturm A; Fiocchi C; Rizzetto M; Pegoraro L; Sategna-Guidetti C; Brizzi MF
    Inflamm Bowel Dis; 2005 Feb; 11(2):91-8. PubMed ID: 15677901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.
    Bisping G; Lügering N; Lütke-Brintrup S; Pauels HG; Schürmann G; Domschke W; Kucharzik T
    Clin Exp Immunol; 2001 Jan; 123(1):15-22. PubMed ID: 11167992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis in the intestinal mucosa of patients with inflammatory bowel disease: evidence of altered expression of FasL and perforin cytotoxic pathways.
    Souza HS; Tortori CJ; Castelo-Branco MT; Carvalho AT; Margallo VS; Delgado CF; Dines I; Elia CC
    Int J Colorectal Dis; 2005 May; 20(3):277-86. PubMed ID: 15503066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic options to modulate barrier defects in inflammatory bowel disease.
    Hering NA; Schulzke JD
    Dig Dis; 2009; 27(4):450-4. PubMed ID: 19897959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive intestinal T helper cell profiling reveals specific accumulation of IFN-γ+IL-17+coproducing CD4+ T cells in active inflammatory bowel disease.
    Globig AM; Hennecke N; Martin B; Seidl M; Ruf G; Hasselblatt P; Thimme R; Bengsch B
    Inflamm Bowel Dis; 2014 Dec; 20(12):2321-9. PubMed ID: 25248005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential roles of neutrophils in regulating intestinal mucosal inflammation of inflammatory bowel disease.
    Zhou GX; Liu ZJ
    J Dig Dis; 2017 Sep; 18(9):495-503. PubMed ID: 28857501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperexpression of inducible costimulator and its contribution on lamina propria T cells in inflammatory bowel disease.
    Sato T; Kanai T; Watanabe M; Sakuraba A; Okamoto S; Nakai T; Okazawa A; Inoue N; Totsuka T; Yamazaki M; Kroczek RA; Fukushima T; Ishii H; Hibi T
    Gastroenterology; 2004 Mar; 126(3):829-39. PubMed ID: 14988837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell-directed therapies in inflammatory bowel diseases.
    Monteleone G; Caprioli F
    Clin Sci (Lond); 2010 Mar; 118(12):707-15. PubMed ID: 20350293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment.
    Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H
    Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional Specialisation of T Cell Subsets and Apoptosis in the Human Gut Mucosa: Differences Between Ileum and Colon in Healthy Intestine and Inflammatory Bowel Diseases.
    Carrasco A; Fernández-Bañares F; Pedrosa E; Salas A; Loras C; Rosinach M; Aceituno M; Andújar X; Forné M; Zabana Y; Esteve M
    J Crohns Colitis; 2016 Sep; 10(9):1042-54. PubMed ID: 26995182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linking estrogen receptor β expression with inflammatory bowel disease activity.
    Pierdominici M; Maselli A; Varano B; Barbati C; Cesaro P; Spada C; Zullo A; Lorenzetti R; Rosati M; Rainaldi G; Limiti MR; Guidi L; Conti L; Gessani S
    Oncotarget; 2015 Dec; 6(38):40443-51. PubMed ID: 26497217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc gamma receptor signaling in mast cells links microbial stimulation to mucosal immune inflammation in the intestine.
    Chen X; Feng BS; Zheng PY; Liao XQ; Chong J; Tang SG; Yang PC
    Am J Pathol; 2008 Dec; 173(6):1647-56. PubMed ID: 18974296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in human mucosal gamma delta T cell repertoire and function associated with the disease process in inflammatory bowel disease.
    McVay LD; Li B; Biancaniello R; Creighton MA; Bachwich D; Lichtenstein G; Rombeau JL; Carding SR
    Mol Med; 1997 Mar; 3(3):183-203. PubMed ID: 9100225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.